Samir Mitragotri
American chemist (born 1971) From Wikipedia, the free encyclopedia
American chemist (born 1971) From Wikipedia, the free encyclopedia
Samir Mitragotri (born 28 May 1971) is an Indian American professor at Harvard University, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials.[1] He is currently the Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard John A. Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering.[2] Prior to 2017, he was the Duncan and Suzanne Mellichamp Chair Professor at University of California, Santa Barbara.[3] [4]
 | This article contains weasel words: vague phrasing that often accompanies biased or unverifiable information. (August 2022) |
Samir Mitragotri | |
|---|---|
| |
| Born | 28 May 1971 Solapur, India |
| Alma mater | Institute of Chemical Technology B.S., 1992 Massachusetts Institute of Technology M.S. and PhD, 1996 |
| Known for | Drug Delivery, Biomaterials |
| Awards | National Academy of Engineering National Academy of Medicine |
| Scientific career | |
| Fields | Chemical Engineering, Biomedical Engineering |
| Institutions | Harvard University Harvard John A. Paulson School of Engineering and Applied Sciences Wyss Institute for Biologically Inspired Engineering |
| Doctoral advisor | Robert S. Langer, Daniel Blankschtein |
| Doctoral students | Julie Champion |
Mitragotri has invented many novel drug delivery technologies, especially in the fields of transdermal, oral and targeted systems. He invented techniques to deliver drugs transdermally using low-frequency ultrasound,[5] pulsed microjet injector,[6] high throughput skin experimentation,[7] skin penetrating peptides[8] and ionic liquids.[9] He also invented intestinal patches and ionic liquids for oral delivery of proteins.[10][11] Mitragotri also pioneered nanoparticle-enabled cell therapies which use drug-loaded nanoparticles that hitch a ride on red blood cells, monocytes and other circulatory cells for tissue-specific delivery.[12] Mitragotri's technologies are used to develop next generation therapies against diabetes, cancer, psoriasis, hemorrhage, trauma and infections.
Mitragotri has published over 400 research publications, has given over 500 presentations worldwide, and is an inventor on over 200 patents/applications. His publications are cited with an h-index of 122.[13] Mitragotri is a member of the National Academy of Medicine and the National Academy of Inventors. He is also a member of the US National Academy of Engineering since 2015 for the development, clinical translation, and commercialization of transdermal drug delivery systems. He is a co-founder of several companies that are developing products based on his inventions. He received his PhD in chemical engineering at MIT and BS in chemical engineering from the Institute of Chemical Technology. Mitragotri serves on the editorial boards of several journals and has served as the founding editor-in-chief of Bioengineering and Translational Medicine.
Mitragotri's national and international awards include:
Samir Mitragotri has co-founded several companies:
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.
